Qantas boss Alan Joyce has shed more light on its plans to rip out first and business class seats on its A380s, telling the Australian Financial Review it is looking for a model similar to Singapore Airlines and Emirates. Qantas currently has 72 business class seats on its A380,...
Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself.
News » Originally published on asia.businesstraveller.com 11/11/2009 - Filed under: News » Tokyo's secondary airport at Haneda is to allow Singapore Airlines to operate a route from Changi Airport, while JetStar Asia is also seeking to fly there. Singapore Airlines will launch a twice-daily service in October next year, alongside...
Singapore Airlines SIA has posted a net loss of S$159 million ($114.5 million) during its fiscal second quarter mainly due to higher fuel prices. This is a S$482.8 million drop from the net profit of S$323.8 million that the Star Alliance member reported a year before. While the results are...
Traders watch earnings filingswith particular interest, as changes in a company’s ratios can be a good indication whether a company is on the right track, or headed the wrong way.
Gushan Environmental Energy Limited (GU) is scheduled to release its earnings results Wednesday. The company currently has an earnings per share ratio (EPS trailing twelve months) of - .14 and investors are hoping to see that number change. Let’s take a look at the performance of the stock since its previous earnings release.
{loadposition link_newslink1}
{loadposition livevideopromo}
{loadposition homeaccordion2}
{loadposition contentad}
In the past three months, the stock has posted a -29.15% loss in terms of stock price. Over the same period, the Specialty Chemicals industry group has returned a combined .00% 0.
So the eyes of investors turn to this new round of earnings.
Now, good earnings don’t always lead to higher stock prices, but keeping up on earnings is still a vital part of your fundamental stock analysis. Also note that companies often change earnings dates, so you should double-check them often.
When looking at earnings, it’s very helpful to see how stocks compare to others in its industry group. And even though two stocks may not be direct competitors, many analysts and institutional investors still compare them and evaluate them relative to other stocks in their group.
GU is in the Specialty Chemicals industry group where it competes for investor dollars with companies like Oil-Dri Corp. of America (ODC), which is set to release its earnings on 12/08 and last reported a 3.97% gain in quarter-over-quarter EPS.
Another industry peer, KMG Chemicals Inc. (KMGB) released its earnings on 10/13 and last reported a 717.29% gain in QOQ EPS.
Sigma-Aldrich Corporation(SIAL) is the stock with the biggest market cap in the Specialty Chemicals industry at $6.76B. It closed yesterday at $55.57
To better understand how to evaluate earnings announcements and the affect they have on your portfolio, be sure to read Earnings Announcements and EPS.
Investors watch earnings releaseskeenly, as changes in a company’s performance can be a good indication whether a company is on the right track, or headed the wrong way.
Penford Corp. (PENX) is scheduled to release its earnings results Friday. The company currently has an earnings per share ratio (EPS trailing twelve months) of -4.55 and investors are hoping to see that number change. Let’s take a look at the performance of the stock since its previous earnings release.
{loadposition link_newslink1}
{loadposition livevideopromo}
{loadposition homeaccordion2}
{loadposition contentad}
In the past three months, the stock has posted a 2.45% gain in terms of stock price. Over the same period, the Specialty Chemicals industry group has returned a combined 13.84% gain.
So the eyes of investors turn to this new round of earnings.
Now, good earnings don’t always lead to higher stock prices, but keeping up on earnings is still a vital part of your fundamental stock analysis. Also note that companies often change earnings dates, so you should double-check them often.
When looking at earnings, it’s very helpful to see how stocks compare to others in its industry group. And even though two stocks may not be direct competitors, many analysts and institutional investors still compare them and evaluate them relative to other stocks in their group.
PENX is in the Specialty Chemicals industry group where it competes for investor dollars with companies like American Pacific Corp. (APFC), which released its earnings on 08/04 and last reported a -2922.82% decline in quarter-over-quarter EPS.
Another industry peer, Altair Nanotechnologies, Inc. (ALTI) released its earnings on 11/05 and last reported a 1.96% gain in QOQ EPS.
Sigma-Aldrich Corporation(SIAL) is the stock with the biggest market cap in the Specialty Chemicals industry at $6.74B. It closed yesterday at $55.36
To better understand how to evaluate earnings announcements and the affect they have on your portfolio, be sure to read Earnings Announcements and EPS.
Biotech investors interested in seeing more details about these companies and a full list of their related stories can do so by typing the stock ticker symbol into the Stock Quotes box on the right side of the page.Akorn, Inc. (NASDAQ:AKRX) a specialty pharmaceutical company, reported financial results for the third quarter ended September 30, 2009.Allos Therapeutics, Inc. (NASDAQ:ALTH), a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics announced management will present at two upcoming conferences: the Lazard Capital Markets 6th Annual Healthcare Conference and the Windhover Therapeutic Area Partnerships event, where the Company’s Pralatrexate for Peripheral T-cell Lymphoma project was named as one of Windhover’s Top 10 interesting oncology projects.ArQule, Inc. (Nasdaq:ARQL) announced it will present at the Lazard Capital Markets 6th Annual Healthcare Conference on Tuesday, November 17, 2009 at 5:10 p.m. eastern time.Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) announced researchers are scheduled to present data relating to Soliris® (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 51st Annual Meeting of the American Society of Hematology (ASH), to be held December 5 – 8, 2009 at the Ernst N. Morial Convention Center in New Orleans.Biogen Idec Inc. (NASDAQ:BIIB) announced its presentation at the Lazard Capital Markets 6th Annual Healthcare Conference will be webcast live, via the internet, on Tuesday, November 17, 2009 at 10:55a.m. EST.Elan Corporation, plc (NYSE:ELN) announced it will present at the Lazard Capital Markets 6th Annual Healthcare Conference, on Tuesday, November 17, 2009 at; 9:55 a.m. Eastern Time and 2:55 p.m. GMT.Genoptix, Inc. (Nasdaq:GXDX), a specialized laboratory services provider, announced the Company's participation at the Lazard Capital ManaGement 6th Annual Healthcare Conference at The St. Regis Hotel in New York City on November 17-18, 2009.Impax Laboratories, Inc. (NASDAQ:IPXL) announced the Company will present at the Credit Suisse 18th Annual Healthcare Conference on Friday, November 13th, at 10:00 a.m. Mountain Standard time.ImmunoGen, Inc. (Nasdaq:IMGN), a biopharmaceutical company that develops targeted anticancer therapeutics, announced several ImmunoGen poster presentations will be made at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held in Boston, MA, on November 15-19, 2009.The positive mix lift expected as farmers choose to upgrade to next-generation technologies allows Monsanto Company (NYSE:MON) to reconfirm its commitment to double its 2007 gross profit in 2012, Monsanto President and CEO Hugh Grant will tell investors.Santarus, Inc. (NASDAQ:SNTS), a specialty biopharmaceutical company, announced Gerald T. Proehl, president and chief executive officer, will make a presentation at the Lazard Capital Markets 6th Annual Healthcare Conference on Tuesday, November 17, 2009, at 10:55 a.m. Eastern time (7:55 a.m. Pacific time) at the St. Regis Hotel in New York City.S3 Investment Company, Inc. (OTC:SIVC) announced the company's wholly owned Redwood Capital subsidiary has received payment valued at over $500,000 in the form of cash and stock from the recent closing of a client equity offering.Sigma-Aldrich® (Nasdaq:SIAL) announced it has entered into an exclusive worldwide distribution agreement with Stemgent, Inc. to offer Stemgent's portfolio of lentivirus-based delivery systems for the generation of induced pluripotent stem (iPS) cells.Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced the U.S. District Court for the District of Delaware has issued a decision in its litigation over the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Takeda Pharmaceuticals North America, Inc.'s Prevacid® (Lansoprazole) SoluTab.Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Tap Pharmaceutical's proton pump inhibitor Prevacid® (lansoprazole) Delayed-Release Capsules, 15 mg and 30 mg. Customers will begin receiving product on November 11, 2009.Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) announced holders of its 4.75% Convertible Senior Subordinated Notes due 2013 have agreed to exchange approximately $109.0 million in aggregate principal amount of those notes and accrued interest for approximately 4.8 million shares of the Company’s common stock, which is approximately 140,000 shares more than the number of shares into which the notes were convertible under their original terms.
JP Morgan gave the Specialty Chemicals industry some bad news as it announced a downgrade on one of its stocks.
Innospec Inc. (IOSP) [Chart - News - Analysis] was downgraded from Overweight » Neutral on 11/2/2009---a negative sign for the stock that investors will have to endure. FYI, JP Morgan uses the following rating scale when analyzing stocks: Overweight, Neutral, Underweight.
{loadposition link_newslink1}
{loadposition livevideopromo}
{loadposition contentad}
Innospec Inc. has an average analyst recommendation score of 2.0 and competes for investment dollars with Lubrizol Corp. (LZ) [Chart - News - Analysis] and Sigma-Aldrich Corporation (SIAL) [Chart - News - Analysis]---two other stocks in the Specialty Chemicals industry that have average analyst recommendation scores of 2.3 and 2.5 respectively.
Analyst recommendations are averaged and scored using the following rating scale:
- 1.0 = Strong Buy
- 2.0 = Buy
- 3.0 = Hold
- 4.0 = Sell
- 5.0 = Strong Sell
Why are Upgrades and Initiations Good and Downgrades Bad?
One event that is almost certain to get a reaction from Wall Street is an analyst upgrade or downgrade. Everyone is looking for an edge in the stock market, and quite often, traders turn to stock analysts to get that edge.
Upgrades and coverage initiations are typically good for stocks because they show that analysts either believe that the stock is going to perform better in the future or that the stock is worth covering and providing analysis on.
Downgrades are typically bad for stocks because they show that analysts believe that the stock is going to perform worse in the future.
A stock analysts is a person---typically employed by a large bank, investment firm or analysis company---who devotes his/her life to learning and making predictions about a company and its future performance.
Stock analysts sift through company reports and filings, talk to company management, probe customers and competitors and basically do whatever they can to find out if a company is healthy and growing or sick and shrinking. Because this is incredibly demanding work, stock analysts typically only monitor one or two companies at a time.
Analysts were expecting Cabot Corp. (CBT) [Chart - News - Analysis] to report earnings of $0.13 for last quarter, but CBT beat expectations with actual earnings of $0.30---17 cents above the consensus estimate.
If you compare last quarter's earnings to the $0.20 the company made per share during the same quarter a year ago, you can see that CBT’s earnings are up this year.
{loadposition link_newslink1}
{loadposition livevideopromo}
{loadposition homeaccordion2}
{loadposition contentad}
Also, if you compare CBT's 15.00% projected earnings-per-share (EPS) growth rate for the next five years with the projected EPS growth rate of 10.91% for the Specialty Chemicals industry as a whole during that same time frame, you can see that analysts expect CBT to outperform the industry in the future---which is a good sign for the stock.
Drilling down a little deeper into the Specialty Chemicals industry, you can see how analysts believe CBT will stack up against some of the other stocks in the industry, like Methanex Corporation (MEOH) [Chart - News - Analysis] and Sigma-Aldrich Corporation (SIAL) [Chart - News - Analysis], in the future. Analysts believe MEOH's earnings are going to grow at a rate of 25.50% while SIAL's earnings are going to grow at a rate of 9.06%.
Earnings season can be a volatile time in the stock market. Check out these videos and articles to be better prepared to take advantage of the large price moves that tend to accompany earnings announcements.
Companies featured in this segment: Medtronic Incorporated (NYSE:MDT), E.ON Climate & Renewables (Xetra:EONGn.DE), Poweo S.A. (EPA:ALPWO), Verbund (WBAG:VER), Essar Steel Limited (BSE:500627), General Motors (NYSE:GM), Severstal (MCX:CHMF), Power Grid Corporation of India (BSE:532898), PetroChina Company Limited (NYSE:PTR), China Petroleum & Chemical Corporation (NYSE:SNP), (NASDAQ:SIAL)
Strategy Lab Panel: Robert Walberg, Kelly Wright, Vad Yazvinski, Ken Kam, John Resse and Ron Prichard. We review each of the strategies and the specific ways in which the strategies work as well as stock picks and pans. From Screening on a quantitative basis to contrarian investing strategies and back, this episode has a great deal of ideas that will help you profit. We yammer about Marijuana legalization and the Democrats looking strong. Then, we explore how that is going to effect your portfolio. Good clean fun...
Market Close Live for Wednesday 6/15/06
Topics covered today:
1) Market Wrap - Biggest rally for market in months
2) The small-cap indices lead the way with gains over 3%
3) Commodity indices form double-bottom
4) Stocks from the PFG RSI Buy Scan
5) Analysis of stock questions
6) Stocks and ETFs mentioned: KUB, FWLT, FLR, VOL, CTCI, CHDN, EN, MIKR, ARIA, XMSR, AZN, SIAL, UAPH, PSPT, MAN, SSI, SEIC, GRMN, PFG, CTRP, HOC, PHG, IMGC, BSC, CAT
7) "Market Close Live" IS NOW available as a "PODCAST" for those who have MP3 player. If you are interested in learning how to get "Market Close Live" on your MP3 player please email info@pennfinancialgroup.com.
***** TO GET YOUR STOCK/MARKET QUESTIONS ANSWERED YOU CAN EMAIL THEM TO: info@pennfinancialgroup.com
All News |
Breaking News |
Featured Stories